Bupropion: uses, dosing, side effects & brands

Wellbutrin SR (Bupropion Hydrochloride) is an aminoketone used to treat Attention Deficit Disorder with Hyperactivity, Depressive Disorder, Tobacco Use Disorder.

The FDA classifies bupropion as an aminoketone. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

The label reports that epidemiological data on first-trimester exposure have not identified an increased risk of congenital malformations overall (international Pregnancy Registry, 675 exposures, and a retrospective cohort of 1,213 exposures). The registry suggested a possible increase in cardiac malformations, but no increased risk for cardiovascular malformations overall has been observed. A National Pregnancy Registry for Antidepressants exists (1-844-405-6185). The label notes risks to the mother from untreated depression and that women who discontinued antidepressants were more likely to relapse. It advises weighing the risks of untreated depression against treatment; discuss any decision with your prescriber. This is what bupropion's FDA label says; whether to use it in pregnancy is your prescriber's decision.

The label reports weight loss, not gain. In short-term MDD trials there was a dose-related decrease in body weight: 14% of patients on 300 mg/day and 19% on 400 mg/day lost >5 lbs versus 6% on placebo, while only 2-3% gained >5 lbs versus 4% on placebo. In longer-term (up to 6 months) seasonal affective disorder trials, 23% of the bupropion group had a weight loss of at least 5 lbs compared with 11% on placebo. Decreased appetite is also listed as an adverse reaction.

The label's dedicated 'Use with Alcohol' section (7.5) reports rare postmarketing cases of adverse neuropsychiatric events or reduced alcohol tolerance in patients who drank alcohol during treatment, and states that alcohol consumption during treatment should be minimized or avoided; the patient-information section likewise advises minimizing or avoiding alcohol. This is not a disulfiram-like reaction. Separately, because bupropion can cause seizures, the label notes that excessive use of alcohol lowers the seizure threshold, and that abrupt discontinuation of alcohol is itself a seizure-risk factor. This is what bupropion's FDA label says; alcohol advice depends on your dose and health, so confirm with your pharmacist.

The label includes a 'To Discontinue... Taper the Dose' instruction (2.5): when stopping treatment, the prescriber steps the patient down from the higher daily dose to a lower daily dose before discontinuing, rather than stopping abruptly. This is a prescriber-managed taper. The label does not describe a discontinuation/withdrawal syndrome with named symptoms, and it states that bupropion is not a controlled substance. (The label's warnings about abrupt discontinuation of alcohol, benzodiazepines, or antiepileptic drugs concern those substances as seizure triggers, not withdrawal from bupropion itself.) The boxed warning is about suicidal thoughts and behaviors, not withdrawal. Do not stop bupropion on your own — any change is a prescriber-managed decision.

The elimination half-life of bupropion is about 21 hours on average (±9 hours) — that is how long the body takes to clear half of a dose. This is the half-life of bupropion itself; it has three active metabolites that build up to higher and longer-lasting levels in the blood (hydroxybupropion about 20 hours, erythrohydrobupropion about 33 hours, threohydrobupropion about 37 hours), so the drug's overall effect lasts longer. The half-life varies between people and is longer in those with liver problems. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run bupropion against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

We track 7 bupropion-containing products in the U.S.: Wellbutrin, Wellbutrin SR, Zyban, Aplenzin, Bupropion Hydrochloride, Forfivo XL and Wellbutrin XL. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

Across the brands we track, bupropion is currently marketed as tablet and tablet, extended release, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Yes. Our catalog lists 1 generic bupropion product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

The FDA's Enforcement database lists 2 recall records whose product description mentions bupropion. The most recent: Bupropion Hydrochloride Extended-Release Tablets USP (XL) (Sep 15, 2025). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

Bupropion works gradually: some people feel more energy or better sleep within the first 1 to 2 weeks, but the full effect on mood usually takes about 4 to 6 weeks. When it is used to help quit smoking, it is typically started 1 to 2 weeks before your quit date so it has time to build up.

Alcohol: the FDA label says to avoid alcohol — see the alcohol section above for what it actually says. Other medicines: we hold source-cited interaction answers for Can you drink alcohol on Wellbutrin?. This is what the FDA label and our cited sources say — it is not a complete list. Your pharmacist can check your own combination.

The everyday side effects listed by MedlinePlus are trouble falling or staying asleep (insomnia), dry mouth, headache, nausea, dizziness, constipation, loss of appetite, sweating, a fine tremor (shaking), and anxiety, agitation or jitteriness. Bupropion is an NDRI (norepinephrine-dopamine reuptake inhibitor), an activating rather than sedating antidepressant, which is why insomnia and jitteriness are typical and why it is generally more weight-neutral and causes fewer sexual side effects than SSRIs — an honest upside for many people. These milder effects often ease as your body adjusts over the first weeks. This is not a complete list; ask your prescriber or pharmacist about any symptom that concerns you.

The defining serious risk is seizures. Per the FDA label, seizure risk is dose-related — roughly 0.1% (1 in 1,000) at 300 mg/day rising to about 0.4% (4 in 1,000) at 400 mg/day — which is why the daily dose should not exceed 400 mg. Get emergency help (call 911) for a seizure. Bupropion is contraindicated if you have a seizure disorder, a current or prior diagnosis of bulimia or anorexia nervosa, or if you are abruptly stopping alcohol, benzodiazepines, barbiturates or antiseizure drugs — all of which further raise seizure risk. Call your doctor right away, per MedlinePlus, for confusion, hallucinations, irrational fears, or a rapid, pounding, or irregular heartbeat, or a manic-type surge of "greatly increased energy, severe trouble sleeping, racing thoughts, reckless behavior." Stop the drug and seek emergency care for signs of a serious allergic reaction: "rash or blisters, itching, hives, swelling" or "difficulty breathing or swallowing."

Yes. Bupropion carries the FDA boxed warning shared by antidepressants: they "increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults" (under 24) in short-term studies. MedlinePlus notes this risk is greatest "with the first few months of treatment and when the dose is increased." Watch for — and have family or caregivers watch for — new or worsening depression, thoughts of harming yourself, extreme worry, agitation, panic attacks, aggression, irritability, or severe insomnia. If any of these appear, contact the prescriber immediately; in the US you can also call or text 988 (Suicide and Crisis Lifeline) any time.

Yes. The FDA label states that treatment with bupropion "can result in elevated blood pressure and hypertension." Because of this, prescribers are advised to check your blood pressure before starting and monitor it periodically during treatment — this matters especially if you already have high blood pressure or take other stimulating medicines. Report headaches, chest pain, or a fast or pounding heartbeat to your doctor. Do not stop bupropion on your own to manage this; blood-pressure monitoring and any dose change are managed by your prescriber.

Activating effects like insomnia, jitteriness, dry mouth and headache tend to show up in the first days to weeks as the medicine takes effect, and for many people these mild effects settle as the body adjusts — MedlinePlus does not give a fixed timeline, so responses vary. The suicidality warning period is specifically the first few months of treatment and any time the dose is raised, which is when monitoring should be closest. Full antidepressant benefit generally takes several weeks, so an early side effect does not mean the drug is not working.

Do not stop bupropion on your own. Whether and how to stop, switch, or change the dose is prescriber-managed. Stopping antidepressants abruptly can cause discontinuation symptoms, so your doctor will usually taper the dose rather than have you quit all at once. If you are having side effects that worry you, contact your prescriber to discuss options rather than skipping doses or discontinuing without guidance.

Bupropion is FDA-approved to treat major depressive disorder and to prevent the seasonal depression of seasonal affective disorder. Under the brand name Zyban, the same drug is approved to help adults quit smoking. It's an atypical antidepressant that acts on dopamine and norepinephrine rather than serotonin, which is why it's much less likely to cause the sexual side effects or weight gain common with SSRIs.

Yes for smoking cessation — the sustained-release form is FDA-approved as Zyban to reduce nicotine cravings and withdrawal, usually started 1–2 weeks before your quit date. For weight loss, bupropion is approved only in combination with naltrexone (the brand Contrave); bupropion alone is sometimes prescribed off-label to blunt appetite, but that use is not FDA-approved and the evidence is limited.

Sometimes. Bupropion is not FDA-approved for ADHD, but because it raises dopamine and norepinephrine, clinicians occasionally use it off-label — particularly for adults who can't take stimulants or who also have depression. It's considered a second-line option; stimulants and FDA-approved non-stimulants like atomoxetine work better for core ADHD symptoms. Bupropion also lowers the seizure threshold, so dose matters.